180 related articles for article (PubMed ID: 10400756)
21. Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.
Plotnicky-Gilquin H; Cyblat-Chanal D; Aubry JP; Champion T; Beck A; Nguyen T; Bonnefoy JY; Corvaïa N
J Virol; 2002 Oct; 76(20):10203-10. PubMed ID: 12239295
[TBL] [Abstract][Full Text] [Related]
22. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
[TBL] [Abstract][Full Text] [Related]
23. Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.
Plotnicky-Gilquin H; Goetsch L; Huss T; Champion T; Beck A; Haeuw JF; Nguyen TN; Bonnefoy JY; Corvaïa N; Power UF
J Virol; 1999 Jul; 73(7):5637-45. PubMed ID: 10364313
[TBL] [Abstract][Full Text] [Related]
24. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
[TBL] [Abstract][Full Text] [Related]
25. Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide.
Corvaïa N; Tournier P; Nguyen TN; Haeuw JF; Power UF; Binz H; Andréoni C
J Infect Dis; 1997 Sep; 176(3):560-9. PubMed ID: 9291300
[TBL] [Abstract][Full Text] [Related]
26. Respiratory syncytial virus F and G protein core fragments fused to HBsAg-binding protein (SBP) induce a Th1-dominant immune response without vaccine-enhanced disease.
Khan IU; Ahmad F; Zhang S; Lu P; Wang J; Xie J; Zhu N
Int Immunol; 2019 Mar; 31(4):199-209. PubMed ID: 30462215
[TBL] [Abstract][Full Text] [Related]
27. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.
Tripp RA; Moore D; Winter J; Anderson LJ
J Virol; 2000 Feb; 74(4):1614-22. PubMed ID: 10644330
[TBL] [Abstract][Full Text] [Related]
28. Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment.
Plotnicky-Gilquin H; Huss T; Aubry JP; Haeuw JF; Beck A; Bonnefoy JY; Nguyen TN; Power UF
Virology; 1999 May; 258(1):128-40. PubMed ID: 10329575
[TBL] [Abstract][Full Text] [Related]
29. Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17.
Monick MM; Powers LS; Hassan I; Groskreutz D; Yarovinsky TO; Barrett CW; Castilow EM; Tifrea D; Varga SM; Hunninghake GW
J Immunol; 2007 Aug; 179(3):1648-58. PubMed ID: 17641031
[TBL] [Abstract][Full Text] [Related]
30. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
Bastien N; Trudel M; Simard C
Virology; 1997 Jul; 234(1):118-22. PubMed ID: 9234952
[TBL] [Abstract][Full Text] [Related]
31. Immunity and immunopathology to respiratory syncytial virus. The mouse model.
Openshaw PJ
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S59-62. PubMed ID: 7551415
[TBL] [Abstract][Full Text] [Related]
32. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus.
Hancock GE; Speelman DJ; Heers K; Bortell E; Smith J; Cosco C
J Virol; 1996 Nov; 70(11):7783-91. PubMed ID: 8892899
[TBL] [Abstract][Full Text] [Related]
33. Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.
Lee J; Klenow L; Coyle EM; Golding H; Khurana S
PLoS Pathog; 2018 Aug; 14(8):e1007262. PubMed ID: 30142227
[TBL] [Abstract][Full Text] [Related]
34. Respiratory syncytial virus promoted the differentiation of Th17 cells in airway microenvironment through activation of Notch-1/Delta3.
Qin L; Qiu K; Hu C; Wang L; Wu G; Tan Y
J Med Microbiol; 2019 Apr; 68(4):649-656. PubMed ID: 30843783
[TBL] [Abstract][Full Text] [Related]
35. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice.
Boelen A; Andeweg A; Kwakkel J; Lokhorst W; Bestebroer T; Dormans J; Kimman T
Vaccine; 2000 Nov; 19(7-8):982-91. PubMed ID: 11115725
[TBL] [Abstract][Full Text] [Related]
36. RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs.
Li N; Zhang L; Zheng B; Li W; Liu J; Zhang H; Zeng R
Hum Vaccin Immunother; 2019; 15(11):2684-2694. PubMed ID: 31021703
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo.
Aung S; Tang YW; Graham BS
J Virol; 1999 Nov; 73(11):8944-9. PubMed ID: 10515999
[TBL] [Abstract][Full Text] [Related]
38. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
[TBL] [Abstract][Full Text] [Related]
39. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
[TBL] [Abstract][Full Text] [Related]
40. Cross-reactive and group-specific immune responses to a neutralizing epitope of the human respiratory syncytial virus fusion protein.
Corvaisier C; Bourgeois C; Pothier P
Arch Virol; 1997; 142(6):1073-86. PubMed ID: 9228999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
